The NHS is set to provide an enhanced stop smoking pill, varenicline, to help tens of thousands of individuals in England who wish to quit smoking. This daily tablet is reported to be as effective as e-cigarettes and more effective than nicotine replacement therapies such as gums and patches.
Details of the Stop Smoking Pill
Previously known under the brand name Champix, varenicline was withdrawn from the NHS due to safety concerns. The newly approved version has been confirmed as safe for use. It works by reducing nicotine cravings and alleviating withdrawal symptoms, making it easier for individuals to stop smoking.
Usage and Effectiveness
The stop smoking pill is available only by prescription, meaning that individuals must consult their GP or a local NHS stop smoking service to obtain it. Research indicates that when combined with behavioral support, varenicline can help approximately one in four people quit smoking for at least six months.
Impact on Public Health
With around 85,000 smokers potentially benefiting each year, the NHS estimates that this initiative could prevent approximately 9,500 smoking-related deaths over the next five years. Smoking remains a leading cause of preventable illness in the UK, with the NHS spending around £2.5 billion annually on smoking-related health issues.
Support for Smokers
Health officials emphasize that while the stop smoking pill is a significant advancement, it should be part of a broader support system for individuals looking to quit. Access to counseling and other resources is essential for maximizing the chances of successfully quitting smoking.